EUVIMEDEUVIMED entdecken
Crossref

RNA‐binding protein PUM2 promotes T‐cell acute lymphoblastic leukemia via competitively binding to RBM5 3′UTR with miR‐28‐5p

Taomin Bai iD, Na Liu iD

European Journal of Haematology · 2023

DOI: 10.1111/ejh.13914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Taomin Bai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: MicroRNAs, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

T‐cell acute lymphoblastic leukemia (T‐ALL) is an aggressive hematologic malignancy, and T‐ALL patients are prone to early disease relapse and suffer from poor outcomes. The crucial function of RNA‐binding proteins (RBPs) has been reported in the progression of cancers by regulating the expression of transcripts. This study aimed to reveal the role and molecular regulatory mechanism of RBP Pumilio2 (PUM2) in T‐ALL.

Methods

The expression of genes was detected by reverse transcription quantitative polymerase chain reaction (RT‐qPCR) and western blot analysis. The viability, proliferation, and apoptosis of T‐ALL cells were evaluated by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide, 5‐ethynyl‐2′‐deoxyuridine, and flow cytometry analysis. Luciferase reporter, RNA pulldown, and RNA immunoprecipitation assays were performed to confirm the binding of PUM2 to RBM5. The combination between RNA‐binding motif protein 5 (RBM5) and microRNA (miR)‐28‐5p was validated using luciferase reporter assay.

Results

Our data revealed that PUM2 was highly expressed in T‐ALL blood samples and cell lines. PUM2 knockdown suppressed the proliferation but accelerated the apoptosis of T‐ALL cells in vitro. Additionally, RBM5 exhibited a low expression level in T‐ALL samples and cells. PUM2 negatively regulated RBM5 via targeting its 3′untranslated region (3′UTR). Moreover, PUM2 competitively bound to RBM5 3′UTR with miR‐28‐5p. Rescue experiments showed that RBM5 knockdown reversed the anti‐tumor effects mediated by PUM2 knockdown in T‐ALL cells.

Conclusion

PUM2 plays as a novel oncogenic RBP in T‐ALL by competitively binding to RBM5 mRNA with miR‐28‐5p.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaHumans3' Untranslated RegionsCell Line, TumorRNA-Binding ProteinsT-LymphocytesCell ProliferationApoptosisDNA-Binding ProteinsCell Cycle ProteinsTumor Suppressor Proteins

Stichwörter der Autor:innen

Pumilio2RNA-binding motif protein 5T-cell acute lymphoblastic leukemiamicroRNA-28-5p

Substanzen

MicroRNAs3' Untranslated RegionsRNA-Binding ProteinsRBM5 protein, humanDNA-Binding ProteinsCell Cycle ProteinsTumor Suppressor ProteinsPUM2 protein, humanMIRN28 microRNA, human

Autor:innen und Institutionen

  • Department of Pediatrics, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.

ORCID-Profile: Taomin Bai, Na Liu

Zitieren

APA

Bai, T., & Liu, N. (2023). RNA‐binding protein PUM2 promotes T‐cell acute lymphoblastic leukemia via competitively binding to RBM5 3′UTR with miR‐28‐5p. European Journal of Haematology. https://doi.org/10.1111/ejh.13914

Vancouver

Bai T, Liu N. RNA‐binding protein PUM2 promotes T‐cell acute lymphoblastic leukemia via competitively binding to RBM5 3′UTR with miR‐28‐5p. European Journal of Haematology. 2023. doi:10.1111/ejh.13914

BibTeX
@article{Bai2023,
  author = {Bai, Taomin and Liu, Na},
  title = {RNA‐binding protein PUM2 promotes T‐cell acute lymphoblastic leukemia via competitively binding to RBM5 3′UTR with miR‐28‐5p},
  journal = {European Journal of Haematology},
  year = {2023},
  doi = {10.1111/ejh.13914}
}
Kostenlos starten →